PLEK2 and lung large cell carcinoma: Specifically, we targeted PLEK2 in MDA-MB-231 (BRCA), H2052 (MESO), KYSE-450 (ESCA), A549 (LUAD), H226 (LUSC), H460 (large cell lung carcinoma), PANC-1 (PAAD), UM-UC-3 (BLCA), and HCT-116 (COAD) cell lines.